These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48 related articles for article (PubMed ID: 210428)
41. The hypotriglyceridemic effect of chenodeoxycholic acid in type IV hyperlipemia. Camarri E; Marcolongo R; Zaccherotti L; Marini G Biomedicine; 1978 Oct; 29(6):193-8. PubMed ID: 216433 [TBL] [Abstract][Full Text] [Related]
42. Hypotriglyceridemic effect of chenodeoxycholic acid after a short time of administration. Camarri E; Marcolongo R; Fici F Int J Clin Pharmacol Biopharm; 1978 Nov; 16(11):527-8. PubMed ID: 365797 [TBL] [Abstract][Full Text] [Related]
43. Influence of chenodeoxycholic acid on serum triglycerides in patients with primary hypertriglyceridemia. Camarri E; Fici F; Marcolongo R Int J Clin Pharmacol Biopharm; 1978 Nov; 16(11):523-6. PubMed ID: 365796 [TBL] [Abstract][Full Text] [Related]
44. [The role and limitations of litholytic therapy of cholesterin cholecystolithiasis. Results in 86 cases treated with chenic acid]. Mortola GP; Anfossi A; Parodi E; Cafiero F; Pezzoli F; Berti Riboli E Minerva Med; 1980 Sep; 71(32):2283-91. PubMed ID: 7432661 [TBL] [Abstract][Full Text] [Related]
45. [Results and prospects of therapy of type IV dyslipidemia with chenic acid]. Camarri E; Marcolongo R; Marini G; Zaccherotti L Minerva Med; 1978 May; 69(23):1561-74. PubMed ID: 210428 [TBL] [Abstract][Full Text] [Related]
46. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy. Oki JC Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166 [TBL] [Abstract][Full Text] [Related]